Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
116 studies found for:    GILLES DE LA TOURETTE SYNDROME
Show Display Options
Rank Status Study
1 Active, not recruiting Pallidal Stimulation and Gilles de la Tourette Syndrome
Condition: Gilles de la Tourette Syndrome
Intervention: Device: Deep brain stimulation
2 Completed Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome
Condition: Gilles de la Tourette's Syndrome
Intervention: Behavioral: Facial expression recognition of emotion
3 Terminated Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome
Conditions: Gilles de la Tourette Syndrome;   Tics
Interventions: Device: rTMS;   Device: Sham rTMS
4 Completed
Has Results
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder
Condition: Tourette Syndrome
Intervention: Drug: AZD5213 and placebo
5 Active, not recruiting Sensory Processing in Tourette Syndrome
Condition: Tourette Syndrome
Interventions: Other: The Sensory Profile;   Other: The Adult/Adolescent Sensory Profile;   Other: Children's Yale-Brown Obsessive Compulsive Scale;   Other: Yale-Brown Obsessive Compulsive Scale;   Other: Yale Global Tic Severity Scale;   Other: Demographic Data
6 Completed Omega-3 Fatty Acids in Tourette's Disorder
Condition: Tourette's Disorder
Interventions: Drug: Omega-3 Fatty Acids;   Drug: Olive oil
7 Recruiting The Pathophysiology of Tourette Syndrome: a Multimodal Study
Condition: Tourette Syndrome
Intervention:
8 Completed A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
Condition: TOURETTE SYNDROME
Intervention: Drug: SD-809
9 Completed Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
Condition: Tourette's Disorder
Intervention: Drug: vigabatrin
10 Completed Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Condition: Tourette's Disorder
Intervention: Drug: aripiprazole
11 Completed Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Condition: Tourette's Disorder
Interventions: Drug: aripiprazole 52.5 mg;   Drug: Matching Placebo;   Drug: Aripiprazole 77.5 mg;   Drug: Aripiprazole 110 mg
12 Completed Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Condition: Tourette's Disorder
Interventions: Drug: aripiprazole;   Drug: Placebo
13 Completed Open-Trial of EPI-743 for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Intervention: Drug: EPI-743
14 Recruiting Transcranial Magnetic Stimulation for Children With Tourette's Syndrome
Condition: Tourette Syndrome
Intervention: Device: Low frequency repetitive transcranial magnetic stimulation
15 Active, not recruiting Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Condition: Tourette's Syndrome
Intervention: Drug: Ecopipam
16 Suspended FAAH Inhibitor Trial for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Interventions: Drug: PF-04457845;   Drug: Placebo
17 Recruiting Tourette Syndrome Deep Brain Stimulation
Condition: Tourette Syndrome
Interventions: Device: DBS System;   Device: DBS System (RBS Setting)
18 Completed MRI Study of Tic Remission in Tourette Syndrome
Condition: Tourette Syndrome
Intervention:
19 Active, not recruiting
Has Results
Brain Stimulation for the Treatment of Tourette Syndrome
Condition: Tourette Syndrome
Intervention: Device: NeuroPace RNS® (responsive neurostimulation) System Deep Brain Stimulator
20 Recruiting The Effect and Safety of Plum-blossom Needle for Tourette Syndrome
Condition: Tourette Syndrome
Interventions: Other: Plum-blossom needle group;   Behavioral: HRT group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.